Echocardiographic indices probe during dexmedetomidine/midazolam - ketamine anesthesia in dogs undergoing ovariohysterectomy

在接受卵巢子宫切除术的犬只中,使用右美托咪定/咪达唑仑-氯胺酮麻醉期间的超声心动图指标探针

阅读:1

Abstract

Cardiovascular and respiratory alterations during anesthesia are of major concern in canines. Thus, it is essential to understand the potential depressant effects of anesthetic drugs on cardio-vascular system; so that, anesthetic procedures are conducted in the best possible way. The objective of the study was to assess and compare the echocardiographic indices during dex-medetomidine and midazolam anesthesia in dogs undergoing elective ovariohysterectomy. Twenty-eight female dogs brought to the department for elective ovariohysterectomy were randomly divided into two groups comprising of 14 each. Sedation was achieved with dex-medetomidine and G(MID). Physiological parameters and echocardiographic indices were evaluated before drug administration (T(0)), after 10 min of sedation (T(1)), after induction (T(2)) and at the end of surgery (T(3)) in both groups. Heart rate was significantly higher at T(1), T(2) and T(3); while, rectal temperature was significantly lower at T(3) in G(MID) compared to the G(DEX.) There was a significant decrease in stroke volume and cardiac output values at T(1) and then, a significant increase at T(2); whereas, there was a non-significant decrease at T(3) in both groups. Ejection fraction and fractional shortening values decreased significantly at T(1), increased significantly at T(2) and then, decreased significantly at the end of surgery (T(3)). Dexmedetomidine-ketamine and midazolam-ketamine combinations provide better hemodynamic and respiratory stability in the dogs undergoing elective ovariohysterectomy. Systolic functions were minimally altered with G(MID) compared to G(DEX). Thus, G(MID) is more cardio stable compared to G(DEX).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。